The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five interacting resistance pathways. Read more…
Epigenetics, everything you always wanted to know
DKFZ, Heidelberg, DE, Thursday 26, January 2017, 13:30-17:00
Keynote speaker: Prof. Henk Stunnenberg, Radboud University Medical Centre, NL
Science café: Applying epigenetics in breast cancer treatment
and the Socio public aspects and modern communication workshop by Rathenau and Biotecture.